News

Podcast

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Author(s):

Miranda Schmalfuhs

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

In this episode of the Pharmaceutical Executive podcast, Bill Grambley, CEO of AllazoHealth, explores:

  • How AI can potentially revolutionize patient engagement and adherence
  • Utilizing patient-level data and predictive modeling
  • How AI can identify individual needs and preferences
  • The importance of ethical considerations and data privacy when leveraging AI in healthcare
  • and more!

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Gen Li
Gen Li
Related Content
President Donald Trump
July 31st 2025

President Trump Issues Letters to 17 Major Pharma Companies Demanding Action on Most-Favored-Nation Order

Mike Hollan
The letter states that the companies have 60 days to meet the President's requirements.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
July 31st 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Credit: Tada Images | stock.adobe.com
July 31st 2025

IGNYTE Trial Investigators Press FDA to Reconsider Replimune CRL Amid Promising Melanoma Data, Leadership Shakeup

Davy James
Following a complete response letter rejecting accelerated approval for RP1 in advanced melanoma, IGNYTE trial investigators are urging the FDA to reevaluate the therapy’s robust survival data, just as agency leadership changes raise new questions.
Peter Ax, UpScriptHealth
July 31st 2025

Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals

Miranda Schmalfuhs
Peter Ax, founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry and how digital health platforms could potentially help offset them.
Vinay Prasad Out as FDA CBER Head
July 31st 2025

Vinay Prasad Out as FDA CBER Head

PharmExec Staff
Vinay Prasad, MD, MPH, departs FDA's Center for Biologics, citing family time and avoiding distraction.
US and EU Finalize Trade Agreement with Pharma Tariffs in Focus
July 31st 2025

US and EU Finalize Trade Agreement with Pharma Tariffs in Focus

Nicholas Saraceno, Editor
The pact introduces a 15% levy on most EU exports, including pharmaceuticals.